Torvoside G



Compound IDCDAMM01282
Common nameTorvoside G
IUPAC name6-methoxy-7,9,13-trimethyl-6-[3-methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosan-16-one
Molecular formulaC34H56O9

Experimental data

Retention time15.23
Adduct[M+H]+
Actual mz609.398
Theoretical mz609.399
Error2.91
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.6982

Identifiers and class information

Inchi keyBDENGJXHUIIQRH-UHFFFAOYNA-N
SmilesO=C1CCC2(C)C(C1)CCC3C2CCC4(C)C3CC5OC(OC)(CCC(C)COC6OC(CO)C(O)C(O)C6O)C(C)C54
SuperclassLipids and lipid-like molecules
ClassSteroids and steroid derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)12
Number of reactive functional groups (#rtvFG)3
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)608.811
Computed dipole moment(dipole)3.866
Total solvent accessible surface area (SASA)863.425
Hydrophobic component of SASA (FOSA)651.113
Hydrophilic component of SASA (FISA)212.311
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1782.89
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)13.7
Free energy of solvation of dipole (dip^2/V)0.0083836
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0317341
Globularity descriptor (glob)0.823551
Predicted polarizability in cubic angstroms (QPpolrz)57.492
Predicted hexadecane/gas partition coefficient (QPlogPC16)16.859
Predicted octanol/gas partition coefficient (QPlogPoct)32.656
Predicted water/gas partition coefficient (QPlogPw)19.947
Predicted octanol/water partition coefficient (QPlogPo/w)2.993
Predicted aqueous solubility (QPlogS)-5.018
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.996
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.387
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)96.062
Predicted brain/blood partition coefficient (QPlogBB)-2.247
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)39.32
Predicted skin permeability, log Kp (QPlogKp)-4.28
PM3 calculated ionization potential (IP(ev))10.452
PM3 calculated electron affinity (EA(eV))-0.689
Number of likely metabolic reactions (#metab)6
Prediction of binding to human serum albumin (QPlogKhsa)0.257
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)66.998
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)144.959
Number of nitrogen and oxygen atoms (#NandO)9
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P08185SERPINA6Corticosteroid binding globulinT88452SEA
Q8TDU6GPBAR1G-protein coupled bile acid receptor 1T86273SEA
P11413G6PDGlucose-6-phosphate 1-dehydrogenaseT63484SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P60568IL2Interleukin-2T61698SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T88452DI0037Asthma[ICD-11: CA23]P08185SERPINA6
T88452DI0339Postoperative inflammation[ICD-11: 1A00-CA43]P08185SERPINA6
T88452DI0362Respiratory system disease[ICD-11: CB40-CB7Z]P08185SERPINA6
T86273DI0417Type 2 diabetes mellitus[ICD-11: 5A11]Q8TDU6GPBAR1
T63484DI0086Chronic obstructive pulmonary disease[ICD-11: CA22]P11413G6PD
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2

Copyright © 2025